Why the study?
Does metformin improve cardiac function and remodeling in a nondiabetic rat model of post-MI heart failure?
Population
Male, nondiabetic, Sprague-Dawley rats subjected to either myocardial infarction (MI) or sham operation.
Comparison
Metformin-containing water (250 mg·kg·day) for… vs Normal water (MI control).
Design
Preclinical, Randomly allocated
Follow-up
12 weeks
Authors
Loading...
May attenuate post-MI remodeling in nondiabetic models; leaves open translation to human HF therapy.
Does metformin improve cardiac function and remodeling in a nondiabetic rat model of post-MI heart failure?
Metformin attenuates adverse cardiac remodeling and preserves left ventricular function after myocardial infarction in a nondiabetic rat model.
Yin et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: